Ischemic preconditioning, retinal neuroprotection and histone deacetylase activities

被引:11
|
作者
Fan, Jie [1 ]
Alsarraf, Oday [1 ]
Chou, C. James [1 ]
Yates, Phillip W. [1 ]
Goodwin, Nicole C. [2 ,3 ]
Rice, Dennis S. [2 ]
Crosson, Craig E. [1 ]
机构
[1] Med Univ S Carolina, Storm Eye Inst, Dept Ophthalmol, 167 Ashley Ave, Charleston, SC 29425 USA
[2] Lexicon Pharmaceut, The Woodlands, TX 77381 USA
[3] GlaxoSmithKline, 709 Swedeland Rd, King Of Prussia, PA 19406 USA
基金
美国国家卫生研究院;
关键词
Retina; Neuroprotection; Protein acetylation; Ischemia; Preconditioning; HDAC; GANGLION-CELLS; INJURY; ACETYLATION; PROTECTS; DEGENERATION; TOLERANCE; MODEL; INHIBITION; MECHANISMS; INDUCTION;
D O I
10.1016/j.exer.2016.03.026
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Increased histone deacetylase (HDAC) activity and the resulting dysregulation of protein acetylation is an integral event in retinal degenerations associated with ischemia and ocular hypertension. This study investigates the role of preconditioning on the process of acetylation in ischemic retinal injury. Rat eyes were unilaterally subjected to retinal injury by 45 min of acute ischemia, and retinal neuroprotection induced by 5 min of an ischemic preconditioning (IPC) event. HDAC activity was evaluated by a fluorometric enzymatic assay with selective isoform inhibitors. Retinal localization of acetylated histone-H3 was determined by immunohistochemistry on retina cross sections. Cleaved caspase-3 level was evaluated by Western blots. Electroretinogram (ERG) analyses were used to assess differences in retinal function seven days following ischemic injury. In control eyes, analysis of HDAC isoforms demonstrated that HDAC1/2 accounted for 28.4 +/- 1.6%, HDAC3 for 42.4 +/- 1.5% and HDAC6 activity 27.3 +/- 3.5% of total activity. Following ischemia, total Class-I HDAC activity increased by 21.2 +/- 6.2%, and this increase resulted solely from a rise in HDAC1/2 activity. No change in HDAC3 activity was measured. Activity of Class-II HDACs and HDAC8 was negligible. IPC stimulus prior to ischemic injury also suppressed the rise in Class-I HDAC activity, cleaved caspase-3 levels, and increased acetylated histone-H3 in the retina. In control animals 7 days post ischemia, ERG a- and b-wave amplitudes were significantly reduced by 34.9 +/- 3.1% and 42.4 +/- 6.3%, respectively. In rats receiving an IPC stimulus, the ischemia-induced decline in ERG a- and b-wave amplitudes was blocked. Although multiple HDACs were detected in the retina, these studies provide evidence that hypoacetylation associated with ischemic injury results from the selective rise in HDAC1/2 activity and that neuroprotection induced by IPC is mediated in part by suppressing HDAC activity. (c) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 50 条
  • [1] Histone Deacetylases in Retinal Injury and Ischemic Preconditioning
    Alsarraf, Oday
    Fan, Jie
    Yates, Phillip W.
    Crosson, Craig E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [2] Neuroprotection by histone deacetylase-related protein
    Morrison, BE
    Majdzadeh, N
    Lyles, A
    Bassel-Duby, R
    Olson, EN
    D'Mello, SR
    MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (09) : 3550 - 3564
  • [3] Regulation of histone deacetylase activities
    Sengupta, N
    Seto, E
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 93 (01) : 57 - 67
  • [4] Molecular targets of histone deacetylase inhibitors in neurodegeneration and neuroprotection
    Park, Yeongwon
    Yu, Shangfei
    Hwang, Seung Yong
    Seo, Hyemyung
    MOLECULAR & CELLULAR TOXICOLOGY, 2025, 21 (01) : 1 - 9
  • [5] Novel mediators of ischemic preconditioning induced neuroprotection
    Dhodda, VK
    Sailor, K
    Dempsey, RJ
    Vemuganti, RLR
    JOURNAL OF NEUROCHEMISTRY, 2002, 81 : 108 - 108
  • [6] Anticancer activities of histone deacetylase inhibitors
    Bolden, Jessica E.
    Peart, Melissa J.
    Johnstone, Ricky W.
    NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (09) : 769 - 784
  • [7] Anticancer activities of histone deacetylase inhibitors
    Jessica E. Bolden
    Melissa J. Peart
    Ricky W. Johnstone
    Nature Reviews Drug Discovery, 2006, 5 : 769 - 784
  • [8] Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation
    Zhang, ZhenZhen
    Qin, XiuHong
    Tong, Nianting
    Zhao, XinFeng
    Gong, YuanYuan
    Shi, Yuhua
    Wu, XingWei
    EXPERIMENTAL EYE RESEARCH, 2012, 94 (01) : 98 - 108
  • [9] Measurement of histone acetyltransferase and histone deacetylase activities and kinetics of histone acetylation
    Sun, JM
    Spencer, VA
    Chen, HY
    Li, L
    Davie, JR
    METHODS, 2003, 31 (01) : 12 - 23
  • [10] HISTONE DEACETYLASE 6 INHIBITORS AND NEUROPROTECTION: EVIDENCES AND MOLECULAR MECHANISMS
    Squarzoni, Angelica
    Donzelli, Elisabetta
    Rodriguez-Menendez, Virginia
    Cavaletti, Guido
    Scuteri, Arianna
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S44 - S45